PACCAR Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? PACCAR Inc. Common Stock trades at $109.43 (market cap $57.14B), while Vir Biotechnology Inc. Common Stock trades at $10.38 (market cap $1.76B). The key difference: PACCAR Inc. Common Stock is far larger — about 32.5× Vir Biotechnology Inc. Common Stock's market cap, and PACCAR Inc. Common Stock pays a 1.29% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold PACCAR Inc. Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| PCAR | VIR | |
|---|---|---|
Market Cap | $57.14B | $1.76B |
Volume | 2,748,310 | 2,764,948 |
Sector | Industrials | Health |
52-Week High | $138.21 | $11.78 |
52-Week Low | $94.15 | $5.12 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $63.00B | $1.32B |
Dividend Yield | 1.29% | — |
Signals from Pluang's Aura AI — not financial advice
PACCAR (PCAR) trades at $107.98, down 0.14% with bearish technical signals but strong fundamentals including 9% net income margin and 12.76% ROE. Recent earnings beat expectations in Q2 2026 with $1.43 EPS versus $1.36 expected. The company maintains stable cash flows with $4.3B operating cash flow projected for 2026 and recently declared a $0.35 quarterly dividend payable December 2026.
PCAR presents a mixed outlook with Wall Street consensus price target of $134.83 suggesting 25% upside potential, though technical indicators show bearish momentum. Key risks include sector sensitivity to interest rates and industrial cyclicality, while opportunities lie in the company's strong profitability metrics and defensive non-trucking segments representing over 60% of earnings.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
PACCAR designs and manufactures heavy-duty trucks under brands including Peterbilt, Kenworth, and DAF. It also provides parts, financial services, and technology for commercial vehicles.
Read more on PCAR →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →